Anti-tuberculosis drug concentrations in tuberculosis patients with and without diabetes mellitus (English)
- New search for: Kumar, A K Hemanth
- New search for: Chandrasekaran, V
- New search for: Kannan, T
- New search for: Murali, A Lakshmi
- New search for: Lavanya, J
- New search for: Sudha, V
- New search for: Swaminathan, Soumya
- New search for: Ramachandran, Geetha
- New search for: Kumar, A K Hemanth
- New search for: Chandrasekaran, V
- New search for: Kannan, T
- New search for: Murali, A Lakshmi
- New search for: Lavanya, J
- New search for: Sudha, V
- New search for: Swaminathan, Soumya
- New search for: Ramachandran, Geetha
In:
European Journal of Clinical Pharmacology
;
73
, 1
; 65-70
;
2016
-
ISSN:
- Article (Journal) / Electronic Resource
-
Title:Anti-tuberculosis drug concentrations in tuberculosis patients with and without diabetes mellitus
-
Contributors:Kumar, A K Hemanth ( author ) / Chandrasekaran, V ( author ) / Kannan, T ( author ) / Murali, A Lakshmi ( author ) / Lavanya, J ( author ) / Sudha, V ( author ) / Swaminathan, Soumya ( author ) / Ramachandran, Geetha ( author )
-
Published in:European Journal of Clinical Pharmacology ; 73, 1 ; 65-70
-
Publisher:
- New search for: Springer Berlin Heidelberg
- New search for: Springer
-
Place of publication:Berlin
-
Publication date:2016
-
ISSN:
-
ZDBID:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
- New search for: 44.40 / 44.38
- Further information on Basic classification
-
Keywords:
-
Classification:
-
Source:
Table of contents – Volume 73, Issue 1
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
Network meta-analysis of first- and second-generation protease inhibitors for chronic hepatitis C genotype 1: efficacy based on RVR and SVR 24Borba, Helena H. / Wiens, Astrid / Steimbach, Laiza M. / Perlin, Cassio M. / Tonin, Fernanda S. / Pedroso, Maria L. A. / Fernandez-Llimos, Fernando / Pontarolo, Roberto et al. | 2016
- 15
-
Neutralization of EP217609, a new dual-action FIIa/FXa anticoagulant, by its specific antidote avidin: a phase I studyGueret, P. / Combe, S. / Krezel, C. / Fuseau, E. / van Giersbergen, P. L. M. / Petitou, M. / Neuhart, E. et al. | 2016
- 29
-
Hepatic expression of transcription factors affecting developmental regulation of UGT1A1 in the Han Chinese populationNie, Ya-li / He, Hang / Li, Jiang-feng / Meng, Xiang-guang / Yan, Liang / Wang, Pei / Wang, Shu-jie / Bi, Hong-zheng / Zhang, Li-rong / Kan, Quan-cheng et al. | 2016
- 39
-
FOXP3 rs3761548 polymorphism is associated with tacrolimus-induced acute nephrotoxicity in renal transplant patientsWu, Zhuo / Xu, Qinxia / Qiu, Xiaoyan / Jiao, Zheng / Zhang, Ming / Zhong, Mingkang et al. | 2016
- 49
-
Effect of aprepitant, a moderate CYP3A4 inhibitor, on bosutinib exposure in healthy subjectsHsyu, Poe-Hirr / Pignataro, Daniela Soriano / Matschke, Kyle et al. | 2016
- 57
-
Effect of bosutinib on the absorption of dabigatran etexilate mesylate, a P-glycoprotein substrate, in healthy subjectsHsyu, Poe-Hirr / Pignataro, Daniela Soriano / Matschke, Kyle et al. | 2016
- 65
-
Anti-tuberculosis drug concentrations in tuberculosis patients with and without diabetes mellitusKumar, A K Hemanth / Chandrasekaran, V / Kannan, T / Murali, A Lakshmi / Lavanya, J / Sudha, V / Swaminathan, Soumya / Ramachandran, Geetha et al. | 2016
- 71
-
A population pharmacokinetic model to predict oxypurinol exposure in patients on haemodialysisWright, Daniel FB / Doogue, Matthew P. / Barclay, Murray L / Chapman, Peter T / Cross, Nicholas B / Irvine, John H / Stamp, Lisa K et al. | 2016
- 79
-
Adverse drug events in patients with advanced chronic conditions who have a prognosis of limited life expectancy at hospital admissionSevilla-Sanchez, Daniel / Molist-Brunet, Núria / Amblàs-Novellas, Jordi / Roura-Poch, Pere / Espaulella-Panicot, Joan / Codina-Jané, Carles et al. | 2016
- 91
-
Assessing adherence to inhaled corticosteroids in asthma patients using an integrated measure based on primary and secondary adherenceBlais, Lucie / Kettani, Fatima-Zohra / Forget, Amélie / Beauchesne, Marie-France / Lemière, Catherine / Ducharme, Francine M. et al. | 2016
- 99
-
Ergot and non-ergot dopamine agonists and heart failure in patients with Parkinson’s diseaseMontastruc, François / Moulis, Florence / Araujo, Mélanie / Chebane, Leila / Rascol, Olivier / Montastruc, Jean-Louis et al. | 2016
- 105
-
Characteristics and drug use patterns of older antidepressant initiators in GermanyJobski, Kathrin / Schmedt, Niklas / Kollhorst, Bianca / Krappweis, Jutta / Schink, Tania / Garbe, Edeltraut et al. | 2016
- 115
-
Evaluation of methods to estimate missing days’ supply within pharmacy data of the Clinical Practice Research Datalink (CPRD) and The Health Improvement Network (THIN)Lum, Kirsten J. / Newcomb, Craig W. / Roy, Jason A. / Carbonari, Dena M. / Saine, M. Elle / Cardillo, Serena / Bhullar, Harshvinder / Gallagher, Arlene M. / Lo Re, Vincent et al. | 2016
- 125
-
Benefits of a national network of drug information centres: RELISSchjøtt, Jan et al. | 2016
- 127
-
Erratum to: Genotype and co-medication dependent CYP2D6 metabolic activity: effects on serum concentrations of aripiprazole, haloperidol, risperidone, paliperidone and zuclopenthixolPatteet, Lisbeth / Haufroid, Vincent / Maudens, Kristof / Sabbe, Bernard / Morrens, Manuel / Neels, Hugo et al. | 2016